Peritoneal Dialysis clinical trials

Explore recruiting peritoneal dialysis clinical trials.

Recruiting peritoneal dialysis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Peritoneal Dialysis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 Open-Label Study to Evaluate the Safety and Efficacy of DCR-PHXC in Patients With Primary Hyperoxaluria Type 1 and Severe Renal Impairment, With or Without Dialysis

Germany, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and safety trial of intraperitoneal furosemide in patients on peritoneal dialysis

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Plasma and intraperitoneal pharmacokinetics of cefiderocol in peritoneal dialysis patients

Austria

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Study of Glucothera Plus for Peritoneal Dialysis in Children (ASTRA)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR)

Sweden, Spain, Germany, Denmark, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

PHARMACOKINETICS OF CEFEPIME AFTER INTRAPERITONEAL ADMINISTRATION VIA CYCLER-THERAPY IN APD PATIENTS WITHOUT PERITONITIS

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Peritoneal Dialysis trials by city

Peritoneal Dialysis in Toronto Peritoneal Dialysis in Vancouver Peritoneal Dialysis in Montreal Peritoneal Dialysis in Calgary Peritoneal Dialysis in Edmonton Peritoneal Dialysis in Ottawa Peritoneal Dialysis in Winnipeg Peritoneal Dialysis in Quebec City Peritoneal Dialysis in Hamilton Peritoneal Dialysis in Kitchener Peritoneal Dialysis in London Peritoneal Dialysis in Halifax Peritoneal Dialysis in New York Peritoneal Dialysis in Los Angeles Peritoneal Dialysis in Chicago Peritoneal Dialysis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease